Emergent Biosolutions EBS Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's tax on share settlement?
- Emergent Biosolutions (EBS) reported tax on share settlement of $2.8M in Q1 2026.
- How has Emergent Biosolutions's tax on share settlement changed year-over-year?
- Emergent Biosolutions's tax on share settlement increased by 460.0% year-over-year, from $500K to $2.8M.
- What is the long-term trend for Emergent Biosolutions's tax on share settlement?
- Over 4 years (2021 to 2025), Emergent Biosolutions's tax on share settlement has grown at a -43.6% compound annual growth rate (CAGR), from $13.8M to $1.4M.
- What does tax on share settlement mean?
- Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.